Apimeds Pharmaceuticals US, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

Q: Mar 31 2026

FY: Dec 31 2025

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

Q: Mar 31 2025

FY: Dec 31 2024

FY: Dec 31 2024

FY: Dec 31 2024

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Other Events

Material Modifications to Rights of Security Holders

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Other Events

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Entry into a Material Definitive Agreement

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Other Events

Completion of Acquisition or Disposition of Assets

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Certification of approval for listing and registration on a national securities exchange

Registration of Securities on Exchange

Notice of Effectiveness

Free Writing Prospectus

Amended Initial Registration Statement

Amended Initial Registration Statement

Amended Initial Registration Statement

Amended Initial Registration Statement

Amended Initial Registration Statement

Amended Initial Registration Statement

Amended Initial Registration Statement

No description available

No description available

Inscobee Inc.

Inscobee Inc.

Inscobee Inc.

Ayrton Capital LLC

Inscobee Inc.

Inscobee Inc.

Koo Jakap

O'DONNELL CAROL A

Kogan Elona

Yoon Hankil

Weintraub Bennett

Kogan Elona

O'DONNELL CAROL A

Weintraub Bennett

Yoon Hankil

Kim Christopher

Emerson Erik C.

Koo Jakap

Inscobee Inc.

Inscobee Inc.

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

No description available

Draft registration statement (confidential submission) (amendment)